BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24498917)

  • 1. Soluble thrombomodulin attenuates sinusoidal obstruction syndrome in rat through suppression of high mobility group box 1.
    Nakamura K; Hatano E; Miyagawa-Hayashino A; Okuno M; Koyama Y; Narita M; Seo S; Taura K; Uemoto S
    Liver Int; 2014 Nov; 34(10):1473-87. PubMed ID: 24498917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sorafenib attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats through suppression of JNK and MMP-9.
    Nakamura K; Hatano E; Narita M; Miyagawa-Hayashino A; Koyama Y; Nagata H; Iwaisako K; Taura K; Uemoto S
    J Hepatol; 2012 Nov; 57(5):1037-43. PubMed ID: 22796153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble Thrombomodulin Attenuates Endothelial Cell Damage in Hepatic Sinusoidal Obstruction Syndrome.
    Takada S; Miyashita T; Yamamoto Y; Kanou S; Munesue S; Ohbatake Y; Nakanuma S; Okamoto K; Sakai S; Kinoshita J; Makino I; Nakamura K; Tajima H; Takamura H; Ninomiya I; Fushida S; Ohta T
    In Vivo; 2018; 32(6):1409-1417. PubMed ID: 30348695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic Effect of Recombinant Human Soluble Thrombomodulin for Hepatic Sinusoidal Obstruction Syndrome Model Mice.
    Kanou S; Miyashita T; Yamamoto Y; Takada S; Nakura M; Okazaki M; Ohbatake Y; Nakanuma S; Makino I; Tajima H; Takamura H; Fushida S; Ohta T
    In Vivo; 2020; 34(3):1037-1045. PubMed ID: 32354890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regorafenib suppresses sinusoidal obstruction syndrome in rats.
    Okuno M; Hatano E; Nakamura K; Miyagawa-Hayashino A; Kasai Y; Nishio T; Seo S; Taura K; Uemoto S
    J Surg Res; 2015 Feb; 193(2):693-703. PubMed ID: 25266603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro effects of the anticoagulant, thrombomodulin, on the inflammatory response in rodent models.
    Hagiwara S; Iwasaka H; Matsumoto S; Hasegawa A; Yasuda N; Noguchi T
    Shock; 2010 Mar; 33(3):282-8. PubMed ID: 19536047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase III inhibitor attenuates rat sinusoidal obstruction syndrome through inhibition of platelet aggregation in Disse's space.
    Miyata T; Tajima H; Hirata M; Nakanuma SI; Makino I; Hayashi H; Oyama K; Miyashita T; Takamura H; Ninomiya I; Fushida S; Iseki S; Harada SI; Wakayama T; Ohta T
    J Gastroenterol Hepatol; 2018 Apr; 33(4):950-957. PubMed ID: 28960464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phosphodiesterase III inhibitor protects rat liver from sinusoidal obstruction syndrome through heme oxygenase-1 induction.
    Narita M; Hatano E; Ikai I; Miyagawa-Hayashino A; Yanagida A; Nagata H; Asechi H; Taura K; Uemoto S
    Ann Surg; 2009 May; 249(5):806-13. PubMed ID: 19387321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic regeneration is decreased in a rat model of sinusoidal obstruction syndrome.
    Schiffer E; Frossard JL; Rubbia-Brandt L; Mentha G; Pastor CM
    J Surg Oncol; 2009 Jun; 99(7):439-46. PubMed ID: 19353590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The flavonoid monoHER prevents monocrotaline-induced hepatic sinusoidal injury in rats.
    Ezzat T; van den Broek MA; Davies N; Dejong CH; Bast A; Malagó M; Dhar DK; Olde Damink SW
    J Surg Oncol; 2012 Jul; 106(1):72-8. PubMed ID: 22287334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombomodulin improved liver injury, coagulopathy, and mortality in an experimental heatstroke model in mice.
    Kawasaki T; Okamoto K; Kawasaki C; Sata T
    Anesth Analg; 2014 May; 118(5):956-63. PubMed ID: 24781566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombomodulin improves rat survival after extensive hepatectomy.
    Ota Y; Kumamoto T; Ishibe A; Watanabe K; Mori R; Taniguchi K; Matsuyama R; Makino H; Ueda M; Kubota T; Akiyama H; Tanaka K; Ichikawa Y; Endo I
    J Surg Res; 2015 Apr; 194(2):375-382. PubMed ID: 25527361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome.
    Soubrane O; Brouquet A; Zalinski S; Terris B; Brézault C; Mallet V; Goldwasser F; Scatton O
    Ann Surg; 2010 Mar; 251(3):454-60. PubMed ID: 20160638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human soluble thrombomodulin decreases the plasma high-mobility group box-1 protein levels, whereas improving the acute liver injury and survival rates in experimental endotoxemia.
    Nagato M; Okamoto K; Abe Y; Higure A; Yamaguchi K
    Crit Care Med; 2009 Jul; 37(7):2181-6. PubMed ID: 19487933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human soluble thrombomodulin prevents acute lung injury in a rat cardiopulmonary bypass model.
    Hirao S; Minakata K; Masumoto H; Yamazaki K; Ikeda T; Minatoya K; Sakata R
    J Thorac Cardiovasc Surg; 2017 Dec; 154(6):1973-1983.e1. PubMed ID: 28645823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin attenuates monocrotaline-induced hepatic sinusoidal obstruction syndrome in rats via activation of Sirtuin-3.
    Ren X; Xu K; Xu J; Mei Q
    J Biochem Mol Toxicol; 2023 Sep; 37(9):e23422. PubMed ID: 37350538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic recombinant thrombomodulin treatment prevents hepatic sinusoidal obstruction syndrome in high-risk pediatric patients that undergo hematopoietic stem cell transplants.
    Yamamoto S; Toyama D; Sugishita Y; Kaneko R; Okamoto N; Koganesawa M; Fujita S; Akiyama K; Matsuno R; Isoyama K
    Pediatr Transplant; 2018 Nov; 22(7):e13269. PubMed ID: 30003636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of recombinant thrombomodulin for lung injury after pneumonectomy via inhibition of high-mobility group box 1 in mice.
    Takahashi Y; Matsutani N; Dejima H; Nakayama T; Okamura R; Uehara H; Kawamura M
    J Trauma Acute Care Surg; 2016 Nov; 81(5):868-875. PubMed ID: 27504958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cilostazol improves the prognosis after hepatectomy in rats with sinusoidal obstruction syndrome.
    Sugita H; Nakanuma S; Munesue S; Ishikawa T; Tokoro T; Takei R; Okazaki M; Kato K; Takada S; Makino I; Ozaki N; Yamamoto Y; Yagi S
    J Gastroenterol Hepatol; 2024 Feb; ():. PubMed ID: 38348885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sinusoidal obstruction syndrome in the animal model: influence on liver surgery.
    Jafari A; Wehner S; Kalff JC; Manekeller S
    Langenbecks Arch Surg; 2017 Feb; 402(1):115-122. PubMed ID: 27585678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.